Syndeio Biosciences
- Biotech or pharma, therapeutic R&D
Clinical-stage biotech company developing synapse-targeted therapies in Phase 2 development supported by novel Boost pharmacology platform
June 16-19, 2025
Boston Convention & Exhibition Center
Clinical-stage biotech company developing synapse-targeted therapies in Phase 2 development supported by novel Boost pharmacology platform